These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9637763)

  • 1. Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor beta 1 subunit.
    Kawashima T; Kawasaki H; Kitamura T; Nojima Y; Morimoto C
    Cell Immunol; 1998 May; 186(1):39-44. PubMed ID: 9637763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical interaction between interleukin-12 receptor beta 2 subunit and Jak2 tyrosine kinase: Jak2 associates with cytoplasmic membrane-proximal region of interleukin-12 receptor beta 2 via amino-terminus.
    Yamamoto K; Shibata F; Miura O; Kamiyama R; Hirosawa S; Miyasaka N
    Biochem Biophys Res Commun; 1999 Apr; 257(2):400-4. PubMed ID: 10198225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity.
    Ling P; Gately MK; Gubler U; Stern AS; Lin P; Hollfelder K; Su C; Pan YC; Hakimi J
    J Immunol; 1995 Jan; 154(1):116-27. PubMed ID: 7527811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of interleukin-3-induced substrate phosphorylation and cell survival by SHP-2 (Src-homology protein tyrosine phosphatase 2).
    Wheadon H; Edmead C; Welham MJ
    Biochem J; 2003 Nov; 376(Pt 1):147-57. PubMed ID: 12935294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS.
    Rajala RV; Anderson RE
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3110-7. PubMed ID: 11726610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of P40 monomer to dimer is an important determinant of IL-12 bioactivity.
    Klinke DJ
    J Theor Biol; 2006 May; 240(2):323-35. PubMed ID: 16448670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S; Barel M; Frade R
    J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine reporter mouse system for screening novel IL12/23 p40-inducing compounds.
    Im W; Kim H; Yun D; Seo SY; Park SH; Locksley RM; Hong S
    Mol Cells; 2005 Oct; 20(2):288-96. PubMed ID: 16267405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
    Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
    Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD28 costimulation is required not only to induce IL-12 receptor but also to render janus kinases/STAT4 responsive to IL-12 stimulation in TCR-triggered T cells.
    Park WR; Park CS; Tomura M; Ahn HJ; Nakahira Y; Iwasaki M; Gao P; Abe R; Hamaoka T; Fujiwara H
    Eur J Immunol; 2001 May; 31(5):1456-64. PubMed ID: 11465102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgD receptor-mediated signal transduction in T cells.
    Lakshmi Tamma SM; Wu Y; Toporovsky I; Lima V; Coico RF
    Cell Immunol; 2001 Feb; 207(2):110-7. PubMed ID: 11243700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes.
    Airoldi I; Guglielmino R; Carra G; Corcione A; Gerosa F; Taborelli G; Trinchieri G; Pistoia V
    Haematologica; 2002 Apr; 87(4):434-42. PubMed ID: 11940489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.
    Sommavilla R; Pasche N; Trachsel E; Giovannoni L; Roesli C; Villa A; Neri D; Kaspar M
    Protein Eng Des Sel; 2010 Aug; 23(8):653-61. PubMed ID: 20551083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8
    Jung K; Ha JH; Kim JE; Kim JA; Kim YJ; Kim CH; Kim YS
    Oncoimmunology; 2018; 7(7):e1438800. PubMed ID: 29900039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL12 receptors and receptor antagonists.
    Presky DH; Gubler U; Chizzonite RA; Gately MK
    Res Immunol; 1995; 146(7-8):439-45. PubMed ID: 8839143
    [No Abstract]   [Full Text] [Related]  

  • 17. Intratumoral expression using a NFkB-based promoter enhances IL12 antitumor efficacy.
    Garaulet G; Pérez-Chacon G; Alarcón H; Alfranca A; Mulero F; Martínez-Torrecuadrada J; Zapata JM; Rodríguez A
    Cancer Gene Ther; 2019 Jul; 26(7-8):216-233. PubMed ID: 30622324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Cell-Surface Vimentin (CSV) as a Sarcoma Target and Development of CSV-Targeted IL12 Immune Therapy.
    Batth IS; Li S
    Adv Exp Med Biol; 2020; 1257():169-178. PubMed ID: 32483739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 12: a new clinical player in cytokine therapy.
    Banks RE; Patel PM; Selby PJ
    Br J Cancer; 1995 Apr; 71(4):655-9. PubMed ID: 7710924
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of IL12 on B-cell subset function.
    Metzger DW; Vogel LA; Van Cleave VH; Lester TL; Buchanan JM
    Res Immunol; 1995; 146(7-8):499-505. PubMed ID: 8839153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.